Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

Biotechnology

Healthcare
$7.06 -2.70%

-$0.26 today

Market cap
$618.50M
Beta
2.00
P/E (TTM)
-5.1
EPS (TTM)
-$1.80
52W Low $4.02High $36.26

Volume 1.18M

Average 1.27M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$146.72M

FY 2025 · Annual

Investing Cash Flow

-$155.76M

FY 2025 · Annual

Financing Cash Flow

$211.30M

FY 2025 · Annual

-21.4% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(71.1M)(104.79M)(96.66M)(129.47M)(162.45M)
Depreciation & Amortization1.66M1.66M377K393K490K
Deferred Income Tax00000
Stock-Based Compensation0017.26M22.58M17.59M
Change in Working Capital2.83M3.02M(589K)9.16M2.78M
Accounts Receivables00000
Inventory00000
Accounts Payables(683K)351K2.32M2.51M4.6M
Other Working Capital3.51M2.67M(2.91M)6.65M(1.82M)
Other Non-Cash Items15.91M18.04M(4.12M)(7.02M)(5.12M)
Operating Cash Flow(50.69M)(82.07M)(83.73M)(104.35M)(146.72M)
Capital Expenditures(1.58M)(363K)0(159K)0
Acquisitions (Net)00000
Purchases of Investments(486.97M)(213.66M)(255.63M)(394.96M)(500.72M)
Sales of Investments213.1M305.5M250.76M301.59M344.96M
Other Investing Activities0014K00
Investing Cash Flow(275.44M)91.48M(4.85M)(93.53M)(155.76M)
Debt Repayment00003M
Common Stock Issued1.39M476K129.74M266.29M208.3M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities003.68M2.53M0
Financing Cash Flow1.39M476K133.42M268.82M211.3M
Effect of Forex Changes00000
Net Change in Cash(324.74M)9.89M44.84M70.94M(91.18M)
Free Cash Flow(52.27M)(82.43M)(83.73M)(104.51M)(146.72M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$162.5M
+ D&A$490.0K
+ Stock-Based Comp$17.6M
+ Deferred Tax$0
+ Working Capital$2.8M
- Other Non-Cash-$5.1M
= Operating Cash Flow-$146.7M
- Capex$0
= Free Cash Flow-$146.7M

Analysis

FY2025 free cash flow is -$146.7M. FCF conversion is 90.3% of net income. Operating cash flow was -$146.7M, with capex of $0. The largest bridge item is Stock-Based Comp at $17.6M.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13D/ASC 13D/A filingOct 16, 2026
8-KCurrent reportOct 15, 2026

Does OLMA generate free cash flow?

Olema Pharmaceuticals, Inc. (OLMA) generated -$146.72M of free cash flow in fiscal 2025.

How much operating cash flow does OLMA produce?

Operating cash flow was -$146.72M, before capital expenditures of $0.00.